| Application no. and date | 97952609.2 (espacenet) (Federated) (European Patent Register), 19971222 | | Patent/reg. no. and date | DK/EP 0951551, 20080716 | | Publication date | 19991027 | | Priority no. and date | US 59978 P, 19961223, US 77181 P, 19970307, US 813509, 19970307, US 64671 P, 19971014 | | EP pub. no. and date |
EP 0951551 19991027 | | Effective date | | | Applicant/owner | Immunex Corporation, One Amgen Center Drive
Thousand Oaks, CA 91320, US | | Applicant ref. no. | P44184DK01 | | Inventor | MARASKOVSKY, Eugene, 4123 Evanston Avenue North
Seattle, WA 98103, US,
GALIBERT, Laurent, J., 617 5th Avenue West
Seattle, WA 98119, US,
ANDERSON, Dirk, M., 3616 NW 64th Street
Seattle, WA 98107, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07K 14/52 (2006.01) , C07K 14/705 (2006.01) , C07K 16/24 (2006.01) , C07K 16/28 (2006.01) , C12N 15/11 (2006.01) , C12N 15/19 (2006.01) , C12N 15/62 (2006.01) | | Title | Ligand for NF-kappa B-receptoraktivator, ligand er medlem af TNF-superfamilien | | Int. application no. | US1997023775 | | Int. publication no. | WO1998028426 | | Related patent (certificate) | CA 2010 00033 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
